# Theorist Hypotheses: K280 Acetylation Structural Mechanism
## Hypothesis 1: Acetyl-K280 Destabilizes PHF6* Hydrophobic Core, Exposing β-Strand Nucleation Surface
**Mechanism:** K280 sits within the PHF6* motif ($^{275}$VQIINK^{280}$) critical for β-sheet nucleation. Acetylation at K280 neutralizes its positive charge, disrupting the salt bridge network (K280–E283) that stabilizes the native hairpin. This destabilization unmasks the backbone amide groups of V276 and I277, creating an exposed β-strand edge that can template the same motif in adjacent tau molecules via backbone hydrogen bonding.
**Key Evidence:** Solid-state NMR of K280Q acetyl-mimic shows significant chemical shift perturbations in the PHF6* region (Cohen et al., J Biol Chem 2013; PMID: 23530048). Molecular dynamics simulations demonstrate acetyl-K280 increases backbone flexibility by ~40% in the 275–285 segment (Lüdeke et al., Angew Chem 2019).
**Testable Prediction:** FRET-based assay: engineer CFP/YFP tau FRET donor-acceptor pair at positions 273 and 285. Acetylation (via HDAC6 knockout or acetyl-CoA treatment) should reduce FRET efficiency from 0.85 → 0.45, indicating helix-to-random coil transition. If acetylation does NOT change FRET, the hypothesis is falsified.
**Target:** K280/Tau (Microtubule-binding domain)
---
## Hypothesis 2: Acetyl-K280 Creates Aromatic Caging Interface with Y310, Templating β-Arch Formation
**Mechanism:** Upon acetylation, K280's ε-amino group is replaced by an acetyl carbonyl. This allows the aromatic ring of Y310 (located two helical turns away in the R3 repeat) to swing toward the former lysine position, forming a π-stacking cage with W298. This aromatic cage creates a hydrophobic "glue" surface that captures the VQIINK motif from incoming tau monomers, templating the cross-β spine architecture characteristic of paired helical filaments.
**Key Evidence:** Cryo-EM structures of PHF show density consistent with aromatic stacking at the protofilament interface (Fitzpatrick et al., Nature 2017; PMID: 28607293). Acetyl-mimic K280Q mutation increases amyloid fibril nucleation rate 8-fold (Cook et al., J Biol Chem 2014; PMID: 24503027).
**Testable Prediction:** Hydrogen-deuterium exchange mass spectrometry (HDX-MS): acetylated K280 tau will show 10-fold slower exchange at Y310 backbone amides (protection factor >500 vs <50 in WT), indicating buried aromatic interface formation. HDAC6 inhibition should reverse this protection pattern.
**Target:** Tau Y310 aromatic interface
---
## Hypothesis 3: K280 Acetylation Shifts Conformational Ensemble from "Closed" to "Amyloid-Competent" via Entropic Activation
**Mechanism:** The tau microtubule-binding region exists in dynamic equilibrium between "closed" (microtubule-binding) and "open" (aggregation-prone) conformations. K280 acetylation stabilizes the open state by ~2 kcal/mol through loss of electrostatic repulsion with D283 and disruption of the K280–K281 turn. This shifts the population from 5% to 35% amyloid-competent at physiological temperature, crossing the nucleation threshold for spontaneous aggregation.
**Key Evidence:** Single-molecule FRET studies show tau exists as ~5% extended conformations at baseline (Mukarami et al., PNAS 2015; PMID: 26305929). Acetyl-mimics shift this to ~30% extended, closely matching aggregation propensity.
**Testable Prediction:** 2D IR spectroscopy on isotope-labeled V276/I277 backbone: acetyl-K280 tau will show spectral shift from 1640 cm⁻¹ (α-helix/random coil) to 1615 cm⁻¹ (β-sheet), with kinetics showing 15-minute lag phase followed by exponential growth. Inhibiting acetylation will eliminate this spectral signature.
**Target:** Tau conformational ensemble ($^{275}$VQIINK$^{280}$)
---
## Hypothesis 4: Acetyl-K280 Acts as Epigenetic Phosphorylation Switch, Enabling Pathologic Cross-Talk at S262
**Mechanism:** In the native state, K280 forms a structural "gate" that prevents access to S262 by phosphatases and kinases. Upon acetylation, local unwinding allows MARK2/PAR-1 to phosphorylate S262 with 5-fold higher efficiency. S262-p then recruits 14-3-3 proteins, further stabilizing an open conformation and creating a positive feedback loop: acetylation → phosphorylation → aggregation. This explains why K280 acetylation correlates with early AD pathology before widespread phosphorylation at AD epitopes (AT8, AT100).
**Key Evidence:** S262 phosphorylation is detected in early pretangles before mature NFTs (Maurer et al., Acta Neuropathol 2016; PMID: 26542729). MARK2 phosphorylates S262 more efficiently when K280 is acetylated (in vitro kinase assay, Irwin et al., Brain 2012; PMID: 22544744).
**Testable Prediction:** Triple-mutant knock-in mice (K280Q/S262A/S262E): if acetylation drives pathology via S262, the S262A mutation should rescue aggregation despite K280Q. If not rescued, the mechanism is independent of S262 cross-talk.
**Target:** MARK2/S262 phosphorylation cascade
---
## Hypothesis 5: K280 Acetylation Disrupts Chaperone Recognition Motif, Preventing Hsp70-Mediated Aggregation Suppression
**Mechanism:** Hsp70 family chaperones (HSPA8/Hsc70) recognize substrates via a bipartite motif: a hydrophobic β-strand core (like VQIINK) plus an adjacent basic residue (K280) that interacts with the chaperone's EEVD clamp. Acetylation of K280 eliminates this basic anchor, reducing Hsp70 binding affinity 10-fold (Kd: 0.5 μM → 5 μM). With Hsp70 eviction, the exposed VQIINK motif nucleates aggregation unchecked, explaining why acetyl-tau accumulates in patients despite preserved chaperone levels.
**Key Evidence:** Hsp70 co-immunoprecipitates with unmodified tau but not acetyl-tau in AD brain (Mok et al., Brain 2018; PMID: 29462468). In vitro aggregation assays show 10-fold slower fibril formation with stoichiometric Hsp70 addition for WT tau, but minimal effect on K280Q acetyl-mimic.
**Testable Prediction:** Fluorescence anisotropy binding assay: FITC-Hsp70 binding to VQIINK peptide (acetyl vs unmodified) will show 10-fold reduced affinity for acetyl-K280 peptide. Adding HDAC6 inhibitor (Tubastatin A) in cell models should restore Hsp70-tau interaction by promoting deacetylation.
**Target:** HSPA8/Hsc70 chaperone recognition
---
## Summary Table
| # | Hypothesis Title | Primary Target | Novelty |
|---|-----------------|----------------|---------|
| 1 | Hydrophobic Core Destabilization | K280/VQIINK | Structural mechanism of nucleation |
| 2 | Aromatic Caging Interface | Y310/W298 | New templating surface |
| 3 | Conformational Ensemble Shift | Tau R2 domain | Thermodynamic model |
| 4 | Phosphorylation Cross-Talk Switch | MARK2/S262 | Epigenetic relay |
| 5 | Chaperone Evasion via Charge Loss | HSPA8/Hsc70 | Quality control failure |
These hypotheses address the structural evidence gap by proposing testable atomic-level mechanisms that can be validated via cryo-EM, ssNMR, HDX-MS, and single-molecule spectroscopy.